Developer docs
API playgroundTry for free, no card

Search company profiles

Rainbow Medical

Full company profile

uuid0009h2h

Namestring
Rainbow Medical
Websiteurl
rainbowmd.com
Company typeenum
Private
Founded yearint
2008
Descriptiontext

Rainbow Medical is a privately held, Israel-based medical device company founded in 2011 and headquartered in Herzliya. The firm positions itself at the vanguard of the medical device industry, per its own short description, and operates with a small team of 11-50 employees. Leadership comprises founder and CEO Efi Cohen Arazi, founder and owner Yossi Gross (a serial medical device entrepreneur), COO Gilad Lorberbaum, and CFO Yossi Cohen — an unusually heavy executive layer for the headcount band, suggesting a multi-venture or incubator-style structure rather than a single-product operating company. Specific product lines, indications, clinical milestones, regulatory approvals, and commercial customers are not disclosed in the available source material.

The company's only documented financing event was a $25,000,000 funding round closed on 2015-02-16, led by Ping An Ventures with participation from Yongjin Group and ZTE — a syndicate anchored by Chinese strategic and financial investors, indicating an early-stage cross-border capital strategy targeting both China market access and Israeli medtech IP. No subsequent funding rounds, partnerships, M&A, product launches, or regulatory milestones have been disclosed in the aggregated source data.

Direct business model mechanics — pricing, reimbursement, go-to-market channels, customer segments, and revenue traction — are not present in the data. The company's web domain (rainbowmd.com) currently displays a default cPanel hosting placeholder rather than an active corporate site, which is an additional negative signal on current operating posture. As a result, the observable footprint is limited to firmographics, leadership, and a single funding event, and the company cannot be characterized beyond a small, founder-led Israeli medical device entity backed principally by Chinese strategic capital.

Short descriptiontext

Rainbow Medical is a privately held Israeli medical device company founded in 2011 in Herzliya, operating with a small team and founder-led management, backed by a 2015 $25M round led by Ping An Ventures.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHerzliya, Israel
HQ citystring
Herzliya
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Keyword5 values
medical device development, medical device innovation, medical device manufacturing, healthcare technology, medtech products
Industry1 code
PRIMARYHLACAPAB
Connected Medical Devices & Wearables (Sensors, Patches, Implantables)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
NAICS code1 code
  • Medical Equipment and Supplies Manufacturing33911
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Devices
Social media profiles2 records
Cost components4 values
Personnel, Technology or R&D, Operations, Supply Chain
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Rainbow Medical operates in the medical device industry, focused on the development, manufacturing, and commercialization of medical device products. The company is positioned at the vanguard of the medical device industry, working on innovative medtech products for healthcare applications.

Differentiator
Functional benefit
Problem solved
Recent move2 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

U.S.-listed medical device company developing an implantable neurostimulation system for obstructive sleep apnea, with direct ties to founder/owner Yossi Gross. Closely comparable to Rainbow Medical in therapeutic area overlap, Israeli R&D origin, and founder lineage.

TypeDirect peer
Description

Israel-headquartered medical device company commercializing Tumor Treating Fields therapy across multiple oncology indications. Directly comparable to Rainbow Medical as a publicly traded Israeli medical device innovator.

TypeDirect peer
Description

Belgium/Israel-based medical device company developing an implantable neurostimulation system for obstructive sleep apnea. Comparable to Rainbow Medical in device modality (implantable neurostim), clinical indication overlap, and Israel R&D footprint.

TypeDirect peer
Description

Israel-based medical device company (acquired by ZOLL/ResMed) focused on sleep apnea diagnostics and home sleep testing. Comparable as an Israeli medical device company operating in adjacent sleep-disordered breathing and connected diagnostic device categories.

TypeDirect peer
Description

Israel-based medical device company (acquired by Medtronic) that developed robotic-assisted spinal surgery systems. Comparable to Rainbow Medical as a successful Israeli medical device exit story with similar R&D-to-commercialization path.

TypeBroad incumbent
Description

Global medical device incumbent with broad therapeutic coverage including cardiac, neuromodulation, and surgical portfolios. A natural strategic acquirer and broad incumbent that competes with and acquires Israeli device innovators like Rainbow Medical.

TypeBroad incumbent
Description

Global medical device incumbent with extensive cardiology, neuromodulation, and surgical portfolios. Comparable as a broad incumbent active in the same end markets where Rainbow Medical's device programs would compete or be acquired.

TypeBroad incumbent
Description

Global medical device incumbent with significant orthopedic, surgical, and neurotechnology businesses. Comparable as a strategic acquirer and broad competitor in medical device categories where Rainbow Medical may eventually compete.

TypeBroad incumbent
Description

Medical device company specializing in neurosurgery, ENT, and regenerative tissue technologies. Comparable to Rainbow Medical in therapeutic focus areas (neurosurgery, neuromodulation) and as a mid-sized strategic acquirer of innovative device IP.

TypeBroad incumbent
Description

U.S.-listed medical device company developing interventional therapies for vascular and neurological conditions, including the REAL Immersive System for rehabilitation. Comparable as a growth-stage public device company in adjacent neurovascular and rehab device markets.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment3 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Rainbow Medical

Medical Devicesrainbowmd.com

Rainbow Medical is a privately held Israeli medical device company founded in 2011 in Herzliya, operating with a small team and founder-led management, backed by a 2015 $25M round led by Ping An Ventures.

What Rainbow Medical does

Rainbow Medical is a privately held, Israel-based medical device company founded in 2011 and headquartered in Herzliya. The firm positions itself at the vanguard of the medical device industry, per its own short description, and operates with a small team of 11-50 employees. Leadership comprises founder and CEO Efi Cohen Arazi, founder and owner Yossi Gross (a serial medical device entrepreneur), COO Gilad Lorberbaum, and CFO Yossi Cohen — an unusually heavy executive layer for the headcount band, suggesting a multi-venture or incubator-style structure rather than a single-product operating company. Specific product lines, indications, clinical milestones, regulatory approvals, and commercial customers are not disclosed in the available source material.

The company's only documented financing event was a $25,000,000 funding round closed on 2015-02-16, led by Ping An Ventures with participation from Yongjin Group and ZTE — a syndicate anchored by Chinese strategic and financial investors, indicating an early-stage cross-border capital strategy targeting both China market access and Israeli medtech IP. No subsequent funding rounds, partnerships, M&A, product launches, or regulatory milestones have been disclosed in the aggregated source data.

Direct business model mechanics — pricing, reimbursement, go-to-market channels, customer segments, and revenue traction — are not present in the data. The company's web domain (rainbowmd.com) currently displays a default cPanel hosting placeholder rather than an active corporate site, which is an additional negative signal on current operating posture. As a result, the observable footprint is limited to firmographics, leadership, and a single funding event, and the company cannot be characterized beyond a small, founder-led Israeli medical device entity backed principally by Chinese strategic capital.

Rainbow Medical firmographics

Firmographics
Name
Rainbow Medical
Website
https://rainbowmd.com
Company type
Private
Founded year
2008
Operating status
Operating
Headcount range
11–50 employees
Short description
Rainbow Medical is a privately held Israeli medical device company founded in 2011 in Herzliya, operating with a small team and founder-led management, backed by a 2015 $25M round led by Ping An Ventures.
Ownership category
akta.pro rank

Rainbow Medical industry classification

Industry
Product category
Medical Devices
NAICS
Medical Equipment and Supplies Manufacturing (33911)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLACAPAB
Connected Medical Devices & Wearables (Sensors, Patches, Implantables)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring

Keywords

  • Medical device development
  • Medical device innovation
  • Medical device manufacturing
  • Healthcare technology
  • Medtech products

Where Rainbow Medical is headquartered

Location

Headquarters

HQ city
Herzliya
HQ country
Israel
HQ region
Middle East

Markets served

Rainbow Medical business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Supply Chain

Rainbow Medical product offering

Product offering

Core offering

Rainbow Medical operates in the medical device industry, focused on the development, manufacturing, and commercialization of medical device products. The company is positioned at the vanguard of the medical device industry, working on innovative medtech products for healthcare applications.

Differentiator

Problem solved

Functional benefit

Companies that use Rainbow Medical

Customer profile

Ideal customer profiles1 record

Rainbow Medical technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Rainbow Medical partnerships and signals

Strategic signal

Recent moves2 records

Expansion highlights2 records

Rainbow Medical competitors and assessment

Company assessment

Direct peers

  • Inspire Medical Systems: U.S.-listed medical device company developing an implantable neurostimulation system for obstructive sleep apnea, with direct ties to founder/owner Yossi Gross. Closely comparable to Rainbow Medical in therapeutic area overlap, Israeli R&D origin, and founder lineage.
  • Novocure: Israel-headquartered medical device company commercializing Tumor Treating Fields therapy across multiple oncology indications. Directly comparable to Rainbow Medical as a publicly traded Israeli medical device innovator.
  • Nyxoah: Belgium/Israel-based medical device company developing an implantable neurostimulation system for obstructive sleep apnea. Comparable to Rainbow Medical in device modality (implantable neurostim), clinical indication overlap, and Israel R&D footprint.
  • Itamar Medical: Israel-based medical device company (acquired by ZOLL/ResMed) focused on sleep apnea diagnostics and home sleep testing. Comparable as an Israeli medical device company operating in adjacent sleep-disordered breathing and connected diagnostic device categories.
  • Mazor Robotics: Israel-based medical device company (acquired by Medtronic) that developed robotic-assisted spinal surgery systems. Comparable to Rainbow Medical as a successful Israeli medical device exit story with similar R&D-to-commercialization path.

Broad incumbents

  • Medtronic: Global medical device incumbent with broad therapeutic coverage including cardiac, neuromodulation, and surgical portfolios. A natural strategic acquirer and broad incumbent that competes with and acquires Israeli device innovators like Rainbow Medical.
  • Boston Scientific: Global medical device incumbent with extensive cardiology, neuromodulation, and surgical portfolios. Comparable as a broad incumbent active in the same end markets where Rainbow Medical's device programs would compete or be acquired.
  • Stryker: Global medical device incumbent with significant orthopedic, surgical, and neurotechnology businesses. Comparable as a strategic acquirer and broad competitor in medical device categories where Rainbow Medical may eventually compete.
  • Integra LifeSciences: Medical device company specializing in neurosurgery, ENT, and regenerative tissue technologies. Comparable to Rainbow Medical in therapeutic focus areas (neurosurgery, neuromodulation) and as a mid-sized strategic acquirer of innovative device IP.
  • Penumbra: U.S.-listed medical device company developing interventional therapies for vascular and neurological conditions, including the REAL Immersive System for rehabilitation. Comparable as a growth-stage public device company in adjacent neurovascular and rehab device markets.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Rainbow Medical social profiles

Digital presence

Rainbow Medical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Rainbow Medical leadership team

Management profile

Number of profiles

Profiles4 records

Rainbow Medical funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Rainbow Medical M&A and investment

M&A and investment

M&A

Investments3 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rainbow Medical

What does Rainbow Medical do?

Rainbow Medical operates in the medical device industry, focused on the development, manufacturing, and commercialization of medical device products. The company is positioned at the vanguard of the medical device industry, working on innovative medtech products for healthcare applications.

Is Rainbow Medical a public or private company?

Rainbow Medical is a private company. It is classified as venture growth investor backed and is currently operating.

When was Rainbow Medical founded?

Rainbow Medical was founded in 2008. It employs 11 to 50 people.

Where is Rainbow Medical based?

Rainbow Medical is headquartered in Herzliya, Israel, in the Middle East region.

Who are Rainbow Medical's main competitors?

Direct peers on record are Inspire Medical Systems, Novocure, Nyxoah, Itamar Medical and Mazor Robotics. Broad incumbents are Medtronic, Boston Scientific, Stryker, Integra LifeSciences and Penumbra.

Does Rainbow Medical have an API?

No public API is recorded for Rainbow Medical.

What industry is Rainbow Medical in?

Rainbow Medical's product category is Medical Devices. Its primary akta.pro industry code is HLACAPAB, Connected Medical Devices & Wearables (Sensors, Patches, Implantables). Its NAICS code is 33911 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FinSMEsVascular Dynamics Closes $20M Equity FinancingVascular Dynamics, an Irvine-based medical device company, raised $20 million in equity financing led by an investment partner of shareholder Rainbow Medical. The company's MobiusHD technology uses an endovascular device to modulate the autonomic nervous system for heart failure treatment. The round also included Lawrence C. Best and existing investors HBM Healthcare Investments and Invus.PharmiWeb.comVascular Dynamics Completes $20 Million Equity Financing to Support Further Clinical Evaluations of MobiusHD DeviceVascular Dynamics, Inc. has closed a $20 million equity financing round led by an investment partner of shareholder Rainbow Medical to support clinical evaluations of its MobiusHD device. The funding will enable the expansion of the ongoing pilot study for the heart failure treatment and prepare for a forthcoming pivotal study. This financial milestone follows the successful enrollment of the 30th patient in the clinical trial and positive initial efficacy results.Business Wire BlogVascular Dynamics Completes $20 Million Equity Financing to Support Further Clinical Evaluations of MobiusHD DeviceVascular Dynamics, Inc. has closed a $20 million equity financing round led by an investment partner of shareholder Rainbow Medical to support clinical evaluations of its MobiusHD device. The funding will enable the expansion of the current pilot study and set the stage for a forthcoming pivotal study for the endovascular implant designed to treat heart failure.PR NewswireNano Retina kondigt voorlopige resultaten aan van de eerste implantatie bij een mens van het NR600 kunstmatige netvliesapparaatNano Retina Ltd., an Israeli medical device company, announced preliminary results from the first human implantation of its NR600 artificial retina device in March 2020 as part of a European multi-center clinical trial of up to 20 patients seeking CE approval. The first two patients, both blind from retinitis pigmentosa, underwent the procedure at University Hospital Leuven in Belgium and reported positive effects on their vision, with one patient who had been completely blind for five years immediately perceiving an image upon device activation. The company, founded in 2009 by Rainbow Medical, expects visual improvements to continue developing over the coming months.PR NewswirePythagoras Medical erhält CE-Kennzeichnung für das System ConfidenHT™Pythagoras Medical, a medical device company founded by Rainbow Medical, announced that its ConfidenHT™ system received European CE marking, validating its nerve-mapping technology for renal denervation (RDN) procedures treating resistant hypertension. The system addresses a key limitation of current RDN procedures, where up to 40% of patients show no improvement due to inaccurate nerve targeting, by providing real-time feedback to identify ablation hotspots and verify procedure effectiveness. The CEO of Rainbow Medical Group stated that CE marking represents clear validation of the ConfidenHT™ technology's approach to improving RDN procedure outcomes.PR NewswirePythagoras Medical obtient le marquage CE pour le système ConfidenHT™Pythagoras Medical announced on March 27, 2018 that its ConfidenHT™ system has received CE marking, making it the first nerve mapping technology to provide real-time guidance during renal denervation (RDN) procedures for patients with resistant hypertension. The system addresses a critical limitation of current RDN technologies, where up to 40% of patients show no improvement due to blind ablation techniques that lack physician feedback. Rainbow Medical, Israel's largest medical device investment group and parent company of Pythagoras Medical, stated this approval validates the technology's unique approach to improving RDN procedure effectiveness.PR NewswireBlueWind Medical Announces the Publication of Breakthrough Results for BLUEWIND-RENOVA™ Implantable Tibial Nerve NeuromodulatorBlueWind Medical published results of the OPTIMIST study on its implantable tibial nerve neuromodulator for overactive bladder. Of 34 patients, 71% achieved at least 50% symptom reduction at 6 months, and 27.6% became dry. The company says the device offers a safer, minimally invasive alternative to existing treatments.PR NewswireEnopace Biomedical Voted # 1 Medical Innovation CompanyEnopace Biomedical was voted the 2017 #1 Medical Innovation Company at TCT in Denver. The award came from 60 companies, with Enopace emerging as the top finalist. Rainbow Medical will continue investing in the company.PR NewswireRainbow Medical to Collaborate With Johnson & Johnson InnovationRainbow Medical announced a collaboration with Medos International Sarl, part of the DePuy Synthes Companies of Johnson & Johnson, to develop a novel minimally-invasive implant therapy for treating spinal degenerative disc disease. The development work, facilitated by Johnson & Johnson Innovation, will be carried out simultaneously in Israel and the USA, including pre-clinical trials and laboratory tests at medical and university centers. The therapy aims to address a condition that is one of the leading causes of lost work days globally, potentially stopping degenerative progression rather than merely alleviating pain.FinSMEsRainbow Medical Raises $25M from Chinese InvestorsRainbow Medical, an Israeli medical device investment company, raised $25M from Chinese investors including Ping An, YongJin, and ZTE. The funds will seed new startups and support existing portfolio companies like Nano Retina and Enopace Biomedical. The company holds 12 companies developing products for chronic conditions.